Stock Update (NYSE:STJ): St. Jude Medical Continues to Expand its Heart Failure Portfolio in the U.S. to Provide Physicians Additional Options for Managing Patients Not Responding to Other Therapies

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced Food and Drug Administration approval and the launch of SyncAV™ CRT software, designed to build upon the company’s first-to-market MultiPoint™ Pacing technology and further optimize St. Read more on this. St. Jude Medical Inc. (STJ) , currently valued at $23.00B, began trading this morning at $80.67. A quick look at the market, the company’s stock traded between $80.61 and $80.91 and has traded between $48.83 and $80.91 over the past 12 months. Priced at 19.85x this year’s forecasted earnings, STJ shares are relatively inexpensive compared to the industry’s 23.26x forward p/e ratio. And for income investors, the company pays shareholders $1.24 per share annually in dividends, yielding 1.54%. Consensus earnings for the current quarter by the 23 sell-side analysts covering the stock is an estimate of $1.06 per share, which would be $0.03 better than the year-ago quarter and a $0.05 sequential increase. Investors should also note that the full-year EPS estimate of $4.06 is a $0.12 better when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $1.55 Billion. If reported, that would be a 9.93% increase over the year-ago quarter. More recently, Sun Trust Rbsn Humphrey downgraded STJ from Buy to Neutral (May 10, 2016). Previously, Credit Suisse downgraded STJ from Outperform to Neutral. When considering if perhaps the stock is under or overvalued, the average price target is $73.53, which is 8.85% below where the stock opened this morning. See more in (NYSE:STJ) Similar Articles: Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical CardioMEMS HF System is Now Guideline Directed Therapy for Heart Failure Patients in Europe Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations